Joshua T Kantrowitz

18PUBLICATIONS
21CO-AUTHORS
Toxicology (incl. clinical toxicology)Landscape ecologyEpidemiological modellingSensory processes, perception and performanceGender psychology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jun 17, 2026
Serotonin type 3 receptor (5-HT3R) antagonists for negative symptoms and cognitive impairment associated with schizophrenia: a systematic review and meta-analysis.

|Apr 24, 2026
A phase 2 randomized controlled trial of luvadaxistat in treatment of adults with cognitive impairment associated with schizophrenia: results from the ERUDITE study.

|Sep 26, 2025
Feasibility of a digital therapeutic for experiential negative symptoms of schizophrenia: results from an exploratory study.

Haig Goenjian, Abhishek Pratap, Cassandra Snipes

|Apr 28, 2025
Assessing the inter-rater reliability of the Schizophrenia Cognition Rating Scale: a non-interventional quantitative study.

Sebastien Tulliez, Stella Karantzoulis, James C Marcus

|Jan 12, 2025
Negative Symptoms in Schizophrenia: An Update on Research Assessment and the Current and Upcoming Treatment Landscape.

Preetika Govil, Joshua T Kantrowitz

|Jan 10, 2025
Knowing is Half the Battle: The Factors Leading to Efficient Recruitment of Representative Samples in Schizophrenia Research.

Joohyun Yoon, Megan R Mayer, Tala Berro

Pageof 3

Frequent Collaborators

4 joint publications

Daniel C Javitt

2 joint publications

Richard S E Keefe

1 joint publications

Ondine Adam

1 joint publications

Jérôme Brunelin